KalVista Pharmaceuticals, Inc.

SUSQUEHANNA INTERNATIONAL GROUP, LLP KALV

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

71,895

Value ($000)

1,161

Weight

0.0%

2020 Q4 - 2025 Q4 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	1,161	0.0%	71,895	12/31/2025
2025 Q3	11/14/2025	4,791	0.0%	393,339	9/30/2025
2025 Q2	8/14/2025	3,326	0.0%	294,198	6/30/2025
2025 Q1	5/14/2025	602	0.0%	52,168	3/31/2025
2024 Q4	2/14/2025	247	0.0%	29,178	12/31/2024
2024 Q3	11/14/2024	206	0.0%	17,821	9/30/2024
2024 Q2	8/15/2024	159	0.0%	13,486	6/30/2024
2024 Q1	5/7/2024	236	0.0%	19,886	3/31/2024
2023 Q4	2/14/2024	330	0.0%	26,971	12/31/2023
2023 Q3	11/14/2023	104	0.0%	10,794	9/30/2023
2023 Q2	8/11/2023	540	0.0%	59,971	6/30/2023
2023 Q1	5/16/2023	268	0.0%	34,065	3/31/2023
2022 Q4	2/14/2023	725	0.0%	107,245	12/31/2022
2022 Q1	5/16/2022	185	0.0%	12,558	3/31/2022
2021 Q4	2/14/2022	402	0.0%	30,423	12/31/2021
2021 Q3	11/15/2021	713	0.0%	40,872	9/30/2021
2021 Q2	8/11/2021	912	0.0%	38,053	6/30/2021
2021 Q1	5/17/2021	1,696	0.0%	66,020	3/31/2021
2020 Q4	2/16/2021	1,435	0.0%	75,583	12/31/2020